These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27401612)

  • 1. Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth.
    Jackson H; Granger D; Jones G; Anderson L; Friel S; Rycroft D; Fieles W; Tunstead J; Steward M; Wattam T; Walker A; Griggs J; Al-Hajj M; Shelton C
    Mol Cancer Res; 2016 Sep; 14(9):859-68. PubMed ID: 27401612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.
    Chartier C; Raval J; Axelrod F; Bond C; Cain J; Dee-Hoskins C; Ma S; Fischer MM; Shah J; Wei J; Ji M; Lam A; Stroud M; Yen WC; Yeung P; Cancilla B; O'Young G; Wang M; Kapoun AM; Lewicki J; Hoey T; Gurney A
    Cancer Res; 2016 Feb; 76(3):713-23. PubMed ID: 26719531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-4 inhibits Wnt/β-catenin signaling through regulation of low-density-lipoprotein receptor-related protein (LRP6) and R-spondin 3.
    Astudillo P; Carrasco H; Larraín J
    Int J Biochem Cell Biol; 2014 Jan; 46():103-12. PubMed ID: 24275095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
    Dong Y; Zhang Y; Kang W; Wang G; Chen H; Higashimori A; Nakatsu G; Go M; Tong JH; Zheng S; To KF; Sung JJ; Yang X; Ng SS; Yu J
    Theranostics; 2019; 9(22):6517-6531. PubMed ID: 31588233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6.
    Binnerts ME; Kim KA; Bright JM; Patel SM; Tran K; Zhou M; Leung JM; Liu Y; Lomas WE; Dixon M; Hazell SA; Wagle M; Nie WS; Tomasevic N; Williams J; Zhan X; Levy MD; Funk WD; Abo A
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14700-5. PubMed ID: 17804805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-type specific potent Wnt signaling blockade by bispecific antibody.
    Lee NK; Zhang Y; Su Y; Bidlingmaier S; Sherbenou DW; Ha KD; Liu B
    Sci Rep; 2018 Jan; 8(1):766. PubMed ID: 29335534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-Spondin family members regulate the Wnt pathway by a common mechanism.
    Kim KA; Wagle M; Tran K; Zhan X; Dixon MA; Liu S; Gros D; Korver W; Yonkovich S; Tomasevic N; Binnerts M; Abo A
    Mol Biol Cell; 2008 Jun; 19(6):2588-96. PubMed ID: 18400942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.
    Fischer MM; Yeung VP; Cattaruzza F; Hussein R; Yen WC; Murriel C; Evans JW; O'Young G; Brunner AL; Wang M; Cain J; Cancilla B; Kapoun A; Hoey T
    Sci Rep; 2017 Nov; 7(1):15270. PubMed ID: 29127379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics of Dkk4 modulates Wnt action and regulates meibomian gland development.
    Sima J; Piao Y; Chen Y; Schlessinger D
    Development; 2016 Dec; 143(24):4723-4735. PubMed ID: 27864382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.
    Hara K; Kageji T; Mizobuchi Y; Kitazato KT; Okazaki T; Fujihara T; Nakajima K; Mure H; Kuwayama K; Hara T; Nagahiro S
    Cancer Lett; 2015 Jan; 356(2 Pt B):496-505. PubMed ID: 25301448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.
    Hao HX; Xie Y; Zhang Y; Charlat O; Oster E; Avello M; Lei H; Mickanin C; Liu D; Ruffner H; Mao X; Ma Q; Zamponi R; Bouwmeester T; Finan PM; Kirschner MW; Porter JA; Serluca FC; Cong F
    Nature; 2012 Apr; 485(7397):195-200. PubMed ID: 22575959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo.
    Lin C; Lu W; Zhai L; Bethea T; Berry K; Qu Z; Waud WR; Li Y
    FEBS Lett; 2011 Oct; 585(19):3120-5. PubMed ID: 21907199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
    Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
    Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Targeting DKK1 and LRP6 Prevents Bone Loss and Improves Fracture Resistance in Multiple Myeloma.
    Simic MK; Mohanty ST; Xiao Y; Cheng TL; Taylor VE; Charlat O; Croucher PI; McDonald MM
    J Bone Miner Res; 2023 Jun; 38(6):814-828. PubMed ID: 36987921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
    Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
    Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line.
    Lee H; Bae S; Choi BW; Yoon Y
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):56-65. PubMed ID: 21699440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct.
    Schlereth B; Fichtner I; Lorenczewski G; Kleindienst P; Brischwein K; da Silva A; Kufer P; Lutterbuese R; Junghahn I; Kasimir-Bauer S; Wimberger P; Kimmig R; Baeuerle PA
    Cancer Res; 2005 Apr; 65(7):2882-9. PubMed ID: 15805290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling.
    Takahashi K; Hosono M; Sato I; Hata K; Wada T; Yamaguchi K; Nitta K; Shima H; Miyagi T
    Int J Cancer; 2015 Oct; 137(7):1560-73. PubMed ID: 25810027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A finger on the pulse of Wnt receptor signaling.
    MacDonald BT; He X
    Cell Res; 2012 Oct; 22(10):1410-2. PubMed ID: 22688894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation.
    Chen J; Yan H; Ren DN; Yin Y; Li Z; He Q; Wo D; Ho MS; Chen Y; Liu Z; Yang J; Liu S; Zhu W
    Cell Signal; 2014 May; 26(5):1068-74. PubMed ID: 24412751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.